Previous studies have reported FLOT1 as a potential marker for HNSCC progression, enhancing the invasion ability of HNSCC cells, and suggesting its role as a biomarker for metastasis [18]. This evidence concerns the gene FLOT1 and head and neck squamous cell carcinoma.